BIOLASE (BIOL) Institutional Ownership $0.0080 0.00 (-33.33%) As of 01/2/2025 Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for BIOLASE (NASDAQ:BIOL)CurrentInstitutional OwnershipPercentage8.79%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$24.91KNumber ofInstitutional Sellers(last 12 months)0 Get BIOL Insider Trade Alerts Want to know when executives and insiders are buying or selling BIOLASE stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIOL Institutional Buying and Selling by Quarter Ad True Market InsidersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 2025 BIOLASE Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC143,537$27K0.0%+1,068.0%0.430% 8/7/2023Acadian Asset Management LLC961,739$67K0.0%N/A92.475% 7/18/2023Avantax Planning Partners Inc.544,053$38K0.0%N/A1.738% 5/9/2023Perkins Capital Management Inc.2,723,481$766K0.7%+5,795.5%10.344% 1/26/2023Perkins Capital Management Inc.46,196$30K0.0%-65.0%0.598% 11/15/2022Essex Investment Management Co. LLC105,318$256K0.0%+62.3%1.473% Get the Latest News and Ratings for BIOL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Armistice Capital LLC699,000$1.70M0.0%+8.2%10.197% 10/24/2022Perkins Capital Management Inc.132,070$321K0.4%+11.6%1.927% 9/23/2022Capital Wealth Alliance LLC68,000$51K0.0%N/A0.993% 8/12/2022Essex Investment Management Co. LLC64,878$297K0.0%-96.0%0.947% 8/2/2022Capital Wealth Alliance LLC68,000$51K0.0%N/A1.100% 7/29/2022Perkins Capital Management Inc.118,300$542K0.6%-96.1%1.915% 5/9/2022Essex Investment Management Co. LLC1,621,992$573K0.1%+2.5%26.271% 5/4/2022Commonwealth Equity Services LLC101,046$35K0.0%+117.8%0.065% 2/10/2022Essex Investment Management Co. LLC1,582,711$617K0.1%+98.0%1.033% 2/10/2022Acadian Asset Management LLC80,790$31K0.0%N/A0.053% 2/10/2022Perkins Capital Management Inc.3,047,030$1.19M0.8%-2.8%1.988% 11/15/2021Marshall Wace LLP752,003$481K0.0%N/A0.497% 11/15/2021Atom Investors LP47,168$30K0.0%N/A0.031% 11/15/2021GSA Capital Partners LLP1,254,547$802K0.1%N/A0.830% 11/12/2021Credit Suisse AG46,016$29K0.0%N/A0.030% 11/9/2021Essex Investment Management Co. LLC799,189$511K0.1%N/A0.529% 10/29/2021Commonwealth Equity Services LLC49,396$31K0.0%N/A0.033% 9/17/2021Virtu Financial LLC220,473$154K0.0%N/A0.146% 8/16/2021State Street Corp541,194$378K0.0%+4,346.6%0.360% 8/16/2021Goldman Sachs Group Inc.172,521$120K0.0%+67.8%0.115% 8/13/2021Renaissance Technologies LLC1,481,536$1.03M0.0%-33.4%0.985% 8/13/2021Geode Capital Management LLC1,209,039$844K0.0%+1.5%0.804% 8/13/2021Vanguard Group Inc.6,971,925$4.87M0.0%-5.0%4.636% 8/11/2021BlackRock Inc.3,010,754$2.10M0.0%-16.0%2.002% 8/10/2021DCM Advisors LLC97,000$68K0.0%-19.2%0.064% 5/19/2021MONECO Advisors LLC35,000$30K0.0%N/A0.023% 5/18/2021Millennium Management LLC205,964$174K0.0%N/A0.137% 5/18/2021Citadel Advisors LLC387,784$327K0.0%N/A0.258% 5/17/2021Goldman Sachs Group Inc.102,817$87K0.0%N/A0.068% 5/13/2021Renaissance Technologies LLC2,223,284$1.87M0.0%+1,140.0%1.477% 5/12/2021Northern Trust Corp276,060$233K0.0%+184.0%0.183% 5/12/2021Geode Capital Management LLC1,191,258$1.00M0.0%+137.0%0.791% 5/7/2021BlackRock Inc.3,583,531$3.02M0.0%+1,225.7%2.380% 4/28/2021Perkins Capital Management Inc.1,655,500$1.40M0.8%+36.1%1.100% How this >10-cent coin is going to outperform Bitcoin (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 20254/20/2021CFO4Life Group LLC33,200$28K0.0%N/A0.022% 2/24/2021Virtu Financial LLC143,370$60K0.0%-46.7%0.098% 2/23/2021Orion Capital Management LLC70,000$29K0.0%N/A0.075% 2/17/2021Invenomic Capital Management LP607,420$253K0.1%+1,103.5%0.650% 2/16/2021Squarepoint Ops LLC515,900$215K0.0%N/A0.552% 2/10/2021Renaissance Technologies LLC179,300$75K0.0%N/A0.192% 2/9/2021Perkins Capital Management Inc.1,216,250$507K0.3%+9.5%1.301% 2/4/2021GSA Capital Partners LLP195,805$82K0.0%N/A0.209% 12/11/2020Virtu Financial LLC269,185$74K0.0%+1,908.5%0.288% (Data available from 1/1/2016 forward) BIOL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIOL shares? During the previous two years, the following institutional investors and hedge funds held shares of BIOLASE shares: Perkins Capital Management Inc. ($766K), Acadian Asset Management LLC ($67K), and Avantax Planning Partners Inc. ($38K), Virtu Financial LLC ($27K).Learn more on BIOL's institutional investors. What percentage of BIOLASE stock is owned by institutional investors? 8.79% of BIOLASE stock is owned by institutional investors. Learn more on BIOL's institutional investor holdings. Which institutional investors have been buying BIOLASE stock? The following institutional investors have purchased BIOLASE stock in the last 24 months: Perkins Capital Management Inc. ($2.68M), Acadian Asset Management LLC ($961.74K), Avantax Planning Partners Inc. ($544.05K), and Virtu Financial LLC ($131.25K). How much institutional buying is happening at BIOLASE? Institutional investors have bought a total of 4,314,325 shares in the last 24 months. This purchase volume represents approximately $85.96M in transactions. Which BIOLASE major shareholders have been selling company stock? The following institutional investors have sold BIOLASE stock in the last 24 months: Perkins Capital Management Inc. ($85.87K). How much institutional selling is happening at BIOLASE? Institutional investors have sold a total of 85,874 shares in the last 24 months. This volume of shares sold represents approximately $5.58M in transactions. Related Companies Sonendo Major Shareholders Motus GI Major Shareholders Zimmer Biomet Major Shareholders Solventum Major Shareholders Smith & Nephew Major Shareholders Penumbra Major Shareholders Glaukos Major Shareholders Stevanato Group Major Shareholders Bausch + Lomb Major Shareholders Inspire Medical Systems Major Shareholders This page (NASDAQ:BIOL) was last updated on 1/4/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.